References
- Andrade, A. S., Deutsch, R., Celano, S., Duarte, N. A., Marcotte, T. D., Umlauf, A., … Collier, A. C. (2013). Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes, 62, 282–292. doi:10.1097/QAI.0b013e31827ed678
- Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., … Schoenbaum, E. E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(8), 1417–1423. doi:10.1086/323201
- Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381. doi:10.1007/s11606–002–0044-3
- Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, B., & Campa, A. (2009). Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. Journal of Acquired Immune Deficiency Syndromes, 50(1), 93–99. doi:10.1097/QAI.0b013e3181900129
- Becker, B. W., Thames, A. D., Woo, E., Castellon, S. A., & Hinkin, C. H. (2011). Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behaviour, 15, 1888–1894. doi:10.1007/s10461-011-9924-z
- Copenhaver, M. M., Lee, I. C., Margolin, A., Bruce, R. D., & Altice, F. L. (2011). Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users. Substance Abuse, 32(1), 16–26. doi:10.1080/08897077.2011.540466
- Ettenhofer, M. L., Foley, J., Castellon, S. A., & Hinkin, C. H. (2010). Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology, 74, 1217–1222. doi:10.1212/WNL.0b013e3181d8c1ca
- Gross, R., Bellamy, S. L., Chapman, J., Han, X., O'Duor, J., Palmer, S. C., … Strom, B. L. (2013). Managed problem solving for antiretroviral therapy adherence: A randomized trial. JAMA Internal Medicine, 173, 300–306. doi:10.1001/jamainternmed.2013.2152
- Letendre, S. (2011). Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Topics in Antiviral Medicine, 19(4), 137–142.
- Wood, E., Montaner, J. S., Yip, B., Tyndall, M. W., Schechter, M. T., O'Shaughnessy, M. V., & Hogg, R. S. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. Canadian Medical Association Journal, 169, 656–661.
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112443/Skyscraper-socialsciences.png"})